Using NIS both as reporter and therapy gene, we demonstrated active MSC recruitment into the tumor stroma of HCC xenografts and a significant therapeutic effect after application of radioiodide [12]. This evidence concerns the gene SLC5A5 and hepatocellular carcinoma.